Claire Beaumont

2.2k total citations · 1 hit paper
27 papers, 1.7k citations indexed

About

Claire Beaumont is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Claire Beaumont has authored 27 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Pharmacology and 8 papers in Molecular Biology. Recurrent topics in Claire Beaumont's work include Pharmacogenetics and Drug Metabolism (9 papers), Analytical Chemistry and Chromatography (8 papers) and Metabolomics and Mass Spectrometry Studies (6 papers). Claire Beaumont is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Analytical Chemistry and Chromatography (8 papers) and Metabolomics and Mass Spectrometry Studies (6 papers). Claire Beaumont collaborates with scholars based in United Kingdom, United States and Australia. Claire Beaumont's co-authors include Philip Quirke, David Kerr, Kelly Handley, Richard Gray, Laura Magill, Iain D. G. Campuzano, Carol V. Robinson, Hugh I. Kim, Hyungjun Kim and Matthew F. Bush and has published in prestigious journals such as Journal of Clinical Oncology, Analytical Chemistry and Molecules.

In The Last Decade

Claire Beaumont

26 papers receiving 1.7k citations

Hit Papers

Value of Mismatch Repair,... 2011 2026 2016 2021 2011 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claire Beaumont United Kingdom 16 765 536 433 377 186 27 1.7k
David Carlile United Kingdom 24 1.1k 1.4× 534 1.0× 134 0.3× 517 1.4× 144 0.8× 55 2.3k
E. Brendel Germany 21 818 1.1× 269 0.5× 76 0.2× 891 2.4× 310 1.7× 53 2.1k
K. Sjövall Sweden 23 546 0.7× 187 0.3× 123 0.3× 315 0.8× 165 0.9× 44 1.9k
David Jones United States 29 819 1.1× 121 0.2× 119 0.3× 792 2.1× 344 1.8× 58 2.4k
Suzhan Zhang China 23 612 0.8× 243 0.5× 88 0.2× 654 1.7× 291 1.6× 60 1.5k
Poh Koon Koh Singapore 17 388 0.5× 238 0.4× 135 0.3× 858 2.3× 449 2.4× 27 1.4k
Ana Ruiz-Garcı́a United States 23 952 1.2× 200 0.4× 78 0.2× 622 1.6× 159 0.9× 65 2.0k
Karthick Vishwanathan United States 24 987 1.3× 140 0.3× 128 0.3× 712 1.9× 129 0.7× 64 2.2k
Stener Kvinnsland Norway 30 1.2k 1.6× 244 0.5× 113 0.3× 734 1.9× 635 3.4× 106 3.0k
Nahoko Kaniwa Japan 32 1.2k 1.6× 436 0.8× 59 0.1× 985 2.6× 184 1.0× 113 3.4k

Countries citing papers authored by Claire Beaumont

Since Specialization
Citations

This map shows the geographic impact of Claire Beaumont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Beaumont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Beaumont more than expected).

Fields of papers citing papers by Claire Beaumont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Beaumont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Beaumont. The network helps show where Claire Beaumont may publish in the future.

Co-authorship network of co-authors of Claire Beaumont

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Beaumont. A scholar is included among the top collaborators of Claire Beaumont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Beaumont. Claire Beaumont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miao, Xiu‐Sheng, Gordon J. Dear, Claire Beaumont, et al.. (2024). Cyanide Trapping of Iminium Ion Reactive Metabolites: Implications for Clinical Hepatotoxicity. Chemical Research in Toxicology. 37(5). 698–710. 3 indexed citations
2.
3.
Chen, Cathy, Adrian Pereira, Xiu‐Sheng Miao, et al.. (2023). Investigation of the human metabolism and disposition of the prolyl hydrolase inhibitor daprodustat using IV microtracer with Entero‐Test bile string. Pharmacology Research & Perspectives. 11(6). e1145–e1145. 3 indexed citations
4.
Beaumont, Claire, Elizabeth A. Sadowski, Richard J. Chappell, et al.. (2019). Using simple radiologic measurements to anticipate surgical challenge in endometrial cancer: a prospective study. International Journal of Gynecological Cancer. 29(1). 102–107. 4 indexed citations
5.
6.
Beaumont, Claire, et al.. (2017). The Acute Effect of Intermittent Fasting on Resting Energy Expenditure in College-Aged Males. TopSCHOLAR (Western Kentucky University). 9(5). 7.
7.
Pickhardt, Perry J., et al.. (2016). Hepatosplenic volumetric assessment at MDCT for staging liver fibrosis. European Radiology. 27(7). 3060–3068. 55 indexed citations
8.
Jean, Pamela L. St., Zhengyu Xue, Nick Carter, et al.. (2016). Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial. Malaria Journal. 15(1). 97–97. 61 indexed citations
9.
Beaumont, Claire, et al.. (2015). Purpurolic acid: A new natural alkaloid from Claviceps purpurea (Fr.) Tul.. Fungal Biology. 120(1). 104–110. 12 indexed citations
10.
Beaumont, Claire, et al.. (2014). Human absorption, distribution, metabolism and excretion properties of drug molecules: a plethora of approaches. British Journal of Clinical Pharmacology. 78(6). 1185–1200. 45 indexed citations
11.
Beaumont, Claire, et al.. (2013). MR Evaluation of Rectal Cancer: Current Concepts. Current Problems in Diagnostic Radiology. 42(3). 99–112. 17 indexed citations
12.
Bloomer, Jackie C., et al.. (2012). Assessment of potential drug interactions by characterization of human drug metabolism pathways using non‐invasive bile sampling. British Journal of Clinical Pharmacology. 75(2). 488–496. 16 indexed citations
13.
Harrell, Andrew W., Sarah Siederer, Graeme Young, et al.. (2012). Metabolism and Disposition of Vilanterol, a Long-Acting β2-Adrenoceptor Agonist for Inhalation Use in Humans. Drug Metabolism and Disposition. 41(1). 89–100. 45 indexed citations
14.
Ostenfeld, Thor, et al.. (2012). Human microdose evaluation of the novel EP1 receptor antagonist GSK269984A. British Journal of Clinical Pharmacology. 74(6). 1033–1044. 13 indexed citations
15.
Hutchins, Gordon, Katie Southward, Kelly Handley, et al.. (2011). Value of Mismatch Repair, KRAS , and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer. Journal of Clinical Oncology. 29(10). 1261–1270. 505 indexed citations breakdown →
16.
Bowers, Gary D., Claire Beaumont, Mehul Dave, et al.. (2011). Evaluation of a chimeric (uPA+/+)/SCID mouse model with a humanized liver for prediction of human metabolism. Xenobiotica. 41(6). 464–475. 30 indexed citations
17.
Beaumont, Claire, Steve Thomas, Darren Robertson, et al.. (2011). Use of Entero‐Test, a simple approach for non‐invasive clinical evaluation of the biliary disposition of drugs. British Journal of Clinical Pharmacology. 72(1). 133–142. 23 indexed citations
18.
Dear, Gordon J., et al.. (2011). Approaches for The Rapid Identification of Drug Metabolites in Early Clinical Studies. Bioanalysis. 3(2). 197–213. 12 indexed citations
19.
Beaumont, Claire, et al.. (2010). Use of the Entero-Test, a Novel Approach for the Noninvasive Capture of Biliary Metabolites in Dogs. Drug Metabolism and Disposition. 38(5). 851–856. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026